Bioinformatics-as-a-Service (BaaS) Market Size, Share, and Trends 2025 to 2034

Bioinformatics-as-a-Service (BaaS) Market (By Service Type: Sequence Analysis, Functional & Structural Analysis, Data Mining & Integration, Genome Assembly & Annotation, Molecular Modeling & Simulation, Customized Workflows, Data Storage & Management, Others; By Deployment Mode: Cloud-Based BaaS, Web-Based Platforms, On-Premises; By Application: Genomics, Transcriptomic, Metabolomics, Drug Discovery & Development, Clinical Diagnostics, Agricultural & Environmental Research; By End User: Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Clinical & Diagnostic Laboratories, Contract Research Organization, Hospitals & Healthcare Providers; By Pricing Model: Subscription-Based, Pay-Per-Use;) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2025 to 2034

Last Updated : October 2025  |  Report Code : 6946  |  Category : Healthcare  |  Format : PDF / PPT / Excel

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology 

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Bioinformatics-as-a-Service (BaaS) Market 

5.1. COVID-19 Landscape: Bioinformatics-as-a-Service (BaaS) Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Bioinformatics-as-a-Service (BaaS) Market, By Service Type

8.1. Bioinformatics-as-a-Service (BaaS) Market, by Service Type

8.1.1. Sequence Analysis

8.1.1.1. Market Revenue and Forecast

8.1.2. Functional & Structural Analysis

8.1.2.1. Market Revenue and Forecast

8.1.3. Data Mining & Integration

8.1.3.1. Market Revenue and Forecast

8.1.4. Genome Assembly & Annotation

8.1.4.1. Market Revenue and Forecast

8.1.5. Molecular Modeling & Simulation

8.1.5.1. Market Revenue and Forecast

8.1.6. Customized Workflows

8.1.6.1. Market Revenue and Forecast

8.1.7. Data Storage & Management

8.1.7.1. Market Revenue and Forecast

8.1.8. Others

8.1.8.1. Market Revenue and Forecast

Chapter 9. Global Bioinformatics-as-a-Service (BaaS) Market, By Deployment Mode

9.1. Bioinformatics-as-a-Service (BaaS) Market, by Deployment Mode

9.1.1. Cloud-Based BaaS

9.1.1.1. Market Revenue and Forecast

9.1.2. Web-Based Platforms

9.1.2.1. Market Revenue and Forecast

9.1.3. On-Premises (Managed Services)

9.1.3.1. Market Revenue and Forecast

Chapter 10. Global Bioinformatics-as-a-Service (BaaS) Market, By Application 

10.1. Bioinformatics-as-a-Service (BaaS) Market, by Application

10.1.1. Genomics

10.1.1.1. Market Revenue and Forecast

10.1.2. Transcriptomics

10.1.2.1. Market Revenue and Forecast

10.1.3. Proteomics

10.1.3.1. Market Revenue and Forecast

10.1.4. Metabolomics

10.1.4.1. Market Revenue and Forecast

10.1.5. Drug Discovery & Development

10.1.5.1. Market Revenue and Forecast

10.1.6. Clinical Diagnostics

10.1.6.1. Market Revenue and Forecast

10.1.7. Agricultural & Environmental Research

10.1.7.1. Market Revenue and Forecast

10.1.8. Others

10.1.8.1. Market Revenue and Forecast

Chapter 11. Global Bioinformatics-as-a-Service (BaaS) Market, By End User

11.1. Bioinformatics-as-a-Service (BaaS) Market, by End User

11.1.1. Pharmaceutical & Biotechnology Companies

11.1.1.1. Market Revenue and Forecast

11.1.2. Academic & Research Institutes

11.1.2.1. Market Revenue and Forecast

11.1.3. Clinical & Diagnostic Laboratories

11.1.3.1. Market Revenue and Forecast

11.1.4. Contract Research Organizations (CRO)

11.1.4.1. Market Revenue and Forecast

11.1.5. Hospitals & Healthcare Providers

11.1.5.1. Market Revenue and Forecast

11.1.6. Agricultural & Environmental Organizations

11.1.6.1. Market Revenue and Forecast

Chapter 12. Global Bioinformatics-as-a-Service (BaaS) Market, By Pricing Model

12.1. Bioinformatics-as-a-Service (BaaS) Market, by Pricing Model

12.1.1. Subscription-Based

12.1.1.1. Market Revenue and Forecast

12.1.2. Pay-Per-Use

12.1.2.1. Market Revenue and Forecast

Chapter 13. Global Bioinformatics-as-a-Service (BaaS) Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Service Type

13.1.2. Market Revenue and Forecast, by Deployment Mode

13.1.3. Market Revenue and Forecast, by Application

13.1.4. Market Revenue and Forecast, by End User

13.1.5. Market Revenue and Forecast, by Pricing Model

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Service Type

13.1.6.2. Market Revenue and Forecast, by Deployment Mode

13.1.6.3. Market Revenue and Forecast, by Application

13.1.6.4. Market Revenue and Forecast, by End User

13.1.6.5. Market Revenue and Forecast, by Pricing Model  

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Service Type

13.1.7.2. Market Revenue and Forecast, by Deployment Mode

13.1.7.3. Market Revenue and Forecast, by Application

13.1.7.4. Market Revenue and Forecast, by End User

13.1.7.5. Market Revenue and Forecast, by Pricing Model

13.2. Europe

13.2.1. Market Revenue and Forecast, by Service Type

13.2.2. Market Revenue and Forecast, by Deployment Mode

13.2.3. Market Revenue and Forecast, by Application

13.2.4. Market Revenue and Forecast, by End User  

13.2.5. Market Revenue and Forecast, by Pricing Model  

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Service Type

13.2.6.2. Market Revenue and Forecast, by Deployment Mode

13.2.6.3. Market Revenue and Forecast, by Application

13.2.7. Market Revenue and Forecast, by End User  

13.2.8. Market Revenue and Forecast, by Pricing Model  

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Service Type

13.2.9.2. Market Revenue and Forecast, by Deployment Mode

13.2.9.3. Market Revenue and Forecast, by Application

13.2.10. Market Revenue and Forecast, by End User

13.2.11. Market Revenue and Forecast, by Pricing Model

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Service Type

13.2.12.2. Market Revenue and Forecast, by Deployment Mode

13.2.12.3. Market Revenue and Forecast, by Application

13.2.12.4. Market Revenue and Forecast, by End User

13.2.13. Market Revenue and Forecast, by Pricing Model

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Service Type

13.2.14.2. Market Revenue and Forecast, by Deployment Mode

13.2.14.3. Market Revenue and Forecast, by Application

13.2.14.4. Market Revenue and Forecast, by End User

13.2.15. Market Revenue and Forecast, by Pricing Model

13.3. APAC

13.3.1. Market Revenue and Forecast, by Service Type

13.3.2. Market Revenue and Forecast, by Deployment Mode

13.3.3. Market Revenue and Forecast, by Application

13.3.4. Market Revenue and Forecast, by End User

13.3.5. Market Revenue and Forecast, by Pricing Model

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Service Type

13.3.6.2. Market Revenue and Forecast, by Deployment Mode

13.3.6.3. Market Revenue and Forecast, by Application

13.3.6.4. Market Revenue and Forecast, by End User

13.3.7. Market Revenue and Forecast, by Pricing Model

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Service Type

13.3.8.2. Market Revenue and Forecast, by Deployment Mode

13.3.8.3. Market Revenue and Forecast, by Application

13.3.8.4. Market Revenue and Forecast, by End User

13.3.9. Market Revenue and Forecast, by Pricing Model

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Service Type

13.3.10.2. Market Revenue and Forecast, by Deployment Mode

13.3.10.3. Market Revenue and Forecast, by Application

13.3.10.4. Market Revenue and Forecast, by End User

13.3.10.5. Market Revenue and Forecast, by Pricing Model

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Service Type

13.3.11.2. Market Revenue and Forecast, by Deployment Mode

13.3.11.3. Market Revenue and Forecast, by Application

13.3.11.4. Market Revenue and Forecast, by End User

13.3.11.5. Market Revenue and Forecast, by Pricing Model

13.4. MEA

13.4.1. Market Revenue and Forecast, by Service Type

13.4.2. Market Revenue and Forecast, by Deployment Mode

13.4.3. Market Revenue and Forecast, by Application

13.4.4. Market Revenue and Forecast, by End User

13.4.5. Market Revenue and Forecast, by Pricing Model

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Service Type

13.4.6.2. Market Revenue and Forecast, by Deployment Mode

13.4.6.3. Market Revenue and Forecast, by Application

13.4.6.4. Market Revenue and Forecast, by End User

13.4.7. Market Revenue and Forecast, by Pricing Model

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Service Type

13.4.8.2. Market Revenue and Forecast, by Deployment Mode

13.4.8.3. Market Revenue and Forecast, by Application

13.4.8.4. Market Revenue and Forecast, by End User

13.4.9. Market Revenue and Forecast, by Pricing Model

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Service Type

13.4.10.2. Market Revenue and Forecast, by Deployment Mode

13.4.10.3. Market Revenue and Forecast, by Application

13.4.10.4. Market Revenue and Forecast, by End User

13.4.10.5. Market Revenue and Forecast, by Pricing Model

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Service Type

13.4.11.2. Market Revenue and Forecast, by Deployment Mode

13.4.11.3. Market Revenue and Forecast, by Application

13.4.11.4. Market Revenue and Forecast, by End User

13.4.11.5. Market Revenue and Forecast, by Pricing Model

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Service Type

13.5.2. Market Revenue and Forecast, by Deployment Mode

13.5.3. Market Revenue and Forecast, by Application

13.5.4. Market Revenue and Forecast, by End User

13.5.5. Market Revenue and Forecast, by Pricing Model

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Service Type

13.5.6.2. Market Revenue and Forecast, by Deployment Mode

13.5.6.3. Market Revenue and Forecast, by Application

13.5.6.4. Market Revenue and Forecast, by End User

13.5.7. Market Revenue and Forecast, by Pricing Model

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Service Type

13.5.8.2. Market Revenue and Forecast, by Deployment Mode

13.5.8.3. Market Revenue and Forecast, by Application

13.5.8.4. Market Revenue and Forecast, by End User

13.5.8.5. Market Revenue and Forecast, by Pricing Model

Chapter 14. Company Profiles

14.1. Illumina, Inc.

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Thermo Fisher Scientific

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Qiagen N.V.

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Agilent Technologies

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Fios Genomics

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Seven Bridges Genomics

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. DNAnexus

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Eagle Genomics

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Genestack

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Partek Incorporated

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The bioinformatics-as-a-service (BaaS) market size is expected to increase from USD 3.75 billion in 2024 to USD 14.56 billion by 2034.

The bioinformatics-as-a-service (BaaS) market is expected to grow at a compound annual growth rate (CAGR) of around 14.53% from 2025 to 2034.

The major players in the bioinformatics-as-a-service (BaaS) market include Illumina, Inc., Thermo Fisher Scientific, Qiagen N.V., Agilent Technologies, Fios Genomics, Seven Bridges Genomics, DNAnexus, Eagle Genomics, Genestack, Partek Incorporated, Sophia Genetics, Advaita Bioinformatics, Biomax Informatics, BGI Genomics, PerkinElmer Informatics, Basepair Technologies, Maverix Biomics, Strand Life Sciences, Geneious (Dotmatics), and Qlucore.

The driving factors of the bioinformatics-as-a-service (BaaS) market are the imperative to convert voluminous biological data into clinically and commercially actionable decisions with speed and defensibility.

North America region will lead the global bioinformatics-as-a-service (BaaS) market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client